Trials / Unknown
UnknownNCT03434912
Identification and Evaluation of Circulating Tumor Cells and Tumor Related Rare Cells in Immunotherapy
Identification and Evaluation of the Potential Biomarkers on Circulating Tumor Cells and Tumor Related Rare Cells in Cancer Patients Undergoing Immunotherapy
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- MiCareo Taiwan Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is designed to evaluate the enumeration of circulating tumor cells and identify the potential biomarkers associated with clinical outcome. The secondary objective is to explore whether the changes of tumor related rare cells associates clinical outcome.
Conditions
Timeline
- Start date
- 2017-05-24
- Primary completion
- 2018-12-30
- Completion
- 2020-04-30
- First posted
- 2018-02-15
- Last updated
- 2018-08-16
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03434912. Inclusion in this directory is not an endorsement.